COMMUNIQUÉS West-GlobeNewswire

Teva et Prestige Biopharma concluent un accord de licence pour la commercialisation de Tuznue® en Europe
21/10/2025
Teva et Prestige annoncent un accord de licence et d’approvisionnement pour la commercialisation de Tuznue ® , un biosimilaire d’Herceptin ® (trastuzumab) produit par Prestige Tuznue ® a reçu l’autorisation de mise sur [...]
Aveanna Announces Launch of Secondary Offering of Common Stock
21/10/2025
ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, [...]
STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025
21/10/2025
DUBLIN, IRELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 second quarter results at 9:00 a.m. ET [...]
Jushi Holdings Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
21/10/2025
BOCA RATON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) , a vertically integrated, multi-state cannabis operator, announced that it expects to report [...]
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
21/10/2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Sotera Health Announces Third-Quarter 2025 Earnings Release Date
21/10/2025
CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare [...]
Raw Garden Acquires “California Love” to Grow Their Clean Cannabis Movement
21/10/2025
Acquisition strengthens Raw Garden’s mission to expand access to clean cannabis across California SANTA BARBARA, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Raw Garden, California’s leader in clean cannabis for over a [...]
Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year
21/10/2025
ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug product facility has [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 42 - 2025
21/10/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 13 Octobre au 17 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 42 - 2025
21/10/2025
Aggregated presentation by day and by market Statement of transactions in own shares from October 13th to October 17th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
21/10/2025
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has acquired an [...]
Glo & Spa-rkle Aesthetics and Medspa Celebrates 700-Plus 5-Star Google Reviews, Cementing Rank as Best Laser Tattoo Removal Medspa in Lubbock, Texas.
21/10/2025
Glo & Spa-rkle Aesthetics and Medical Spa achieves a significant milestone, reinforcing its commitment to excellence in aesthetic and wellness services. Lubbock, TX, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glo & Spa- [...]
beyond|AESTHETICS Owner Leslie Petersen, NP, Accepted into Elite Dr. Mauricio de Maio MD Codes™ Fellowship Program
21/10/2025
Camarillo, CA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- beyond|AESTHETICS is proud to announce that its owner, Leslie Petersen, NP , has been selected as one of only 15 individuals nationally for the highly coveted Dr. [...]
Quercis Pharma and The Galien Foundation to Spotlight Sickle Cell Disease at the 2025 Patient Summit
21/10/2025
NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Quercis Pharma is proud to sponsor Panel 6 — “The Forgotten Patients: A Focus on Sickle Cell Disease” at The Galien Foundation’s 2025 Patient Summit, taking place on Thursday [...]
Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook
21/10/2025
BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of Directors, effective October [...]
Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization
21/10/2025
Company to Exhibit at American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2025 DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Solenic Medical, a medical device company developing an innovative treatment for [...]
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure
21/10/2025
Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart [...]
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
21/10/2025
~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data of the Launch-HTN Trial of lorundrostat [...]
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
21/10/2025
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today [...]

Pages